Clinical Trials Browser

Phase 2 × Completed × treosulfan × Clear all

NCT04965597 2026-03-09

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Congenital amegakaryocytic thrombocytopenia, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Anemia, Hypochromic, Hemoglobinuria, Paroxysmal, Anemia, Diamond-Blackfan

NCT03961919 2023-11-18

FLAT-Auto

Phase 2 Completed

15 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00796068 2023-02-17

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Phase 2 Completed

130 enrolled 21 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT02333058 2020-05-04

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Phase 2 Completed

70 enrolled

Myeloid

Myelodysplastic Syndromes

NCT00491634 2015-12-02

Treosulfan-based Conditioning for Transplantation in AML/MDS

Phase 2 Completed

24 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01063660 2010-02-05

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Phase 2 Completed

75 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01062490 2010-02-04

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Phase 2 Completed

45 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes